|
|
xi | |
|
|
xiii | |
Foreword |
|
xv | |
Preface |
|
xvii | |
Acknowledgments |
|
xxi | |
About the Author |
|
xxiii | |
|
1 Pandemic--An Introduction |
|
|
1 | (16) |
|
|
1 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
Characteristics of Pandemics |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
4 | (1) |
|
High Transmission Rates and Explosiveness |
|
|
4 | (1) |
|
|
4 | (1) |
|
Minimal Population Immunity |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
|
5 | (3) |
|
Notable Pandemics in History |
|
|
8 | (3) |
|
Pandemics, COVID-19, Technology, Data, and Analytics in the 21st Century |
|
|
11 | (2) |
|
|
13 | (1) |
|
|
13 | (4) |
|
2 Data--Management, Strategy, Quality, Governance, and Analytics |
|
|
17 | (14) |
|
Delving into the Definition of Data |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
Big Data versus Traditional Data |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
20 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
22 | (1) |
|
|
23 | (2) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
26 | (1) |
|
|
26 | (1) |
|
|
26 | (1) |
|
|
26 | (2) |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
29 | (2) |
|
3 Trajectory and Stages of a New Disease |
|
|
31 | (24) |
|
|
31 | (1) |
|
New Disease Trajectory--From Darkness to Light |
|
|
32 | (1) |
|
Contagious Disease and Butterfly Effect |
|
|
33 | (1) |
|
Contact Tracing and Disease Transmission |
|
|
33 | (2) |
|
Epidemic, Pandemic, Outbreak, and Endemic |
|
|
35 | (2) |
|
Index Case, Primary Case, Secondary Case, Patient Zero, and Super Spreaders |
|
|
37 | (1) |
|
|
37 | (1) |
|
|
38 | (1) |
|
|
38 | (1) |
|
|
38 | (2) |
|
|
40 | (1) |
|
Epidemiological Parameters |
|
|
41 | (4) |
|
Stages of a Disease and Pandemic Status |
|
|
45 | (1) |
|
Disease Stages as Defined by Centers for Disease Control and Prevention |
|
|
46 | (1) |
|
Disease Stages as Defined by WHO |
|
|
47 | (1) |
|
Stages of Spread of a Pandemic as Defined by Yigitcanlar et al. (2020), Bharat (2020) |
|
|
48 | (1) |
|
|
49 | (2) |
|
|
51 | (1) |
|
|
51 | (4) |
|
4 COVID-19--A Pandemic in the Digital Age |
|
|
55 | (12) |
|
|
55 | (1) |
|
COVID-19 Pandemic Predictions |
|
|
56 | (1) |
|
|
57 | (2) |
|
|
59 | (1) |
|
Who Was Patient Zero in COVID-19? |
|
|
60 | (1) |
|
COVID-19--From a Localized Outbreak into a Global Pandemic |
|
|
60 | (1) |
|
|
60 | (1) |
|
Spread and Impact of COVID-19--What Does the Data Say |
|
|
60 | (3) |
|
|
63 | (1) |
|
|
63 | (4) |
|
5 Data and Pandemic in the Digital World |
|
|
67 | (24) |
|
Data, Technology, Digital World, and Pandemic |
|
|
67 | (1) |
|
Types of Data from a Pandemic Analytics Perspective |
|
|
68 | (1) |
|
|
69 | (1) |
|
Big Data Sources and Pandemic Management |
|
|
70 | (1) |
|
Use of External Data and Data Sharing in a Pandemic |
|
|
71 | (1) |
|
Data Challenges in a Pandemic--COVID-19 as an Example |
|
|
72 | (1) |
|
|
72 | (2) |
|
|
74 | (3) |
|
|
77 | (3) |
|
Data Definition and Metadata |
|
|
80 | (1) |
|
Data Security, Data Protection, and Data Privacy |
|
|
81 | (3) |
|
|
84 | (2) |
|
|
86 | (5) |
|
5 Data Analytics and Pandemic |
|
|
91 | (24) |
|
Pandemics and Data Analytics |
|
|
91 | (2) |
|
Data Analytics Use Cases in the Pandemic |
|
|
93 | (2) |
|
|
95 | (1) |
|
|
95 | (1) |
|
|
95 | (1) |
|
Modeling Infection Severity |
|
|
96 | (1) |
|
Combating Misleading Information |
|
|
96 | (1) |
|
Vaccine Development, Management, and Distribution |
|
|
97 | (3) |
|
Pandemics, Analytics, and Retail |
|
|
100 | (1) |
|
Pandemics, Analytics, and Finance |
|
|
100 | (1) |
|
COVID-19--Examples of Data Analytics Application in Different Industry Sectors |
|
|
101 | (1) |
|
Data Visualization and Its Role in a Pandemic |
|
|
102 | (8) |
|
|
110 | (2) |
|
|
112 | (3) |
|
7 Disease and Pandemic Potential |
|
|
115 | (8) |
|
Pathogens and Pandemic Potential |
|
|
116 | (2) |
|
Factors Determining Pandemic Potential |
|
|
118 | (2) |
|
|
120 | (1) |
|
|
120 | (3) |
|
8 Pandemic and Critical Success Factors |
|
|
123 | (14) |
|
An Introduction to Pandemic Myths and Critical Success Factors |
|
|
123 | (1) |
|
|
123 | (1) |
|
Myth 1 Pandemics Are Public Health Problem Only |
|
|
124 | (1) |
|
Myth 2 Pandemics Are Extremely Rare and Have Short-Term Impacts |
|
|
124 | (1) |
|
Myth 3 Doctors Are Aware of All the Infectious Diseases |
|
|
125 | (1) |
|
Myth 4 Infrastructure, Resources, and Capacity Are There to Detect and Effectively Respond to Pandemics |
|
|
125 | (1) |
|
Myth 5 Disease Emergence Is Unavoidable, and No One Can Do Anything About It |
|
|
125 | (1) |
|
Critical Success Factors to Manage a Pandemic |
|
|
126 | (1) |
|
Government and Leadership |
|
|
127 | (1) |
|
Capacity to Trace, Test, and Treat |
|
|
128 | (1) |
|
|
129 | (1) |
|
Pandemic Preparedness and Strategies |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
131 | (1) |
|
Collaboration, Coordination, and Global Solidarity |
|
|
132 | (1) |
|
|
133 | (1) |
|
|
134 | (3) |
|
9 Pandemic Preparedness and Strategies |
|
|
137 | (12) |
|
|
138 | (2) |
|
|
140 | (4) |
|
Data Strategy and the Pandemic |
|
|
144 | (1) |
|
|
145 | (1) |
|
|
146 | (3) |
|
10 Pandemic--Lessons Learned and Future Ahead |
|
|
149 | (18) |
|
|
149 | (1) |
|
Lessons from Past Pandemics--With Special Reference to 1918 |
|
|
|
|
150 | (1) |
|
COVID-19 Pandemic--Specific Lessons |
|
|
151 | (16) |
|
|
152 | (1) |
|
2 Government and Leadership Lessons |
|
|
153 | (1) |
|
3 Transparency, Effective Governance, and Timely Release of Relevant Information |
|
|
154 | (2) |
|
4 Non-Pharmaceutical Interventions and Pharmaceutical Precautions |
|
|
156 | (1) |
|
5 Robust Health Surveillance System |
|
|
157 | (1) |
|
6 Testing Responsiveness and Resilience of Health Systems and Action Plan to Balloon Healthcare Infrastructure |
|
|
157 | (2) |
|
7 Funding Research and Development (R&D) |
|
|
159 | (1) |
|
8 Opportunities to Use Novel Approaches and Technologies |
|
|
159 | (1) |
|
|
160 | (1) |
|
10 Communication and Collaboration |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
162 | (5) |
Appendix A Abbreviations and Acronyms |
|
167 | (2) |
Appendix B Glossary of Terms |
|
169 | (1) |
References |
|
170 | (1) |
Index |
|
171 | |